vTv Therapeutics (VTVT) Secures Global Partnership for PDE4 Inhibitor HPP737.
- vTv Therapeutics secures global partnership for PDE4 inhibitor HPP737
- Implication of commercial potential and development progress for the drug candidate
vTv Therapeutics (VTVT) Secures Global Partnership for PDE4 Inhibitor HPP737
AI-generated rewrite based on public information. Review official disclosures before trading.